Skip to content

A Trial for Evaluation of Clinical Efficacy and Safety of Healing Stone Navel Belt in Patients With Primary Dysmenorrhea

Clinical Efficacy and Safety of Healing Stone Navel Belt in Patients With Primary Dysmenorrhea

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00842881
Acronym
Healingstone
Enrollment
102
Registered
2009-02-12
Start date
2008-08-31
Completion date
2009-09-30
Last updated
2009-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Dysmenorrhea

Keywords

Healingstone

Brief summary

The purpose of this study is to determine whether Healing stone navel belt is safe and effective in the treatment of Primary Dysmenorrhea.

Interventions

DEVICEHealingstone navel belt

6\ 8hours/day for 3months

Sponsors

Healingstone Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Age : female adults aged 15\ 45 years * Subjects should diagnosed as primary dysmenorrhea, should have a primary dysmenorrhea at least a 1-day during menstrual. * Subjects should have 21\ 42 days menstrual cycle. * menstrual pain : primary dysmenorrhea at least a 1-day during menstruation is over 5 VAS(Visual Analogue Scale) without drug. * Subjects must have no Serious internal medicine. * Subjects must provide signed informed consent prior to participation in any study-related procedures

Exclusion criteria

* Subject that oral contraceptive taken within 3 months * Pregnancy or lactation. * Subject have contraceptive that secrete hormone. * Secondary dysmenorrhea * pelvis inflammatory disease patient * Other diseases or characteristics judged by the investigator to be incompatible with the assessments needed in this study or with reliable instillation of the study.

Design outcomes

Primary

MeasureTime frame
10cm VAS of pain(Dysmenorrhea)5months

Secondary

MeasureTime frame
quality of life (SF-36)7months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026